Typically, cancer cells evade a person’s immune system because it is recognized as that person’s cells. Wagner developed a tumor lysate particle only (TLPO) vaccine that uses a person’s tumor cells to identify particular parts that are then presented back in the body using the vaccine in a way that can stimulate their immune system to gain the ability to detect these cancer cells like an infection, allowing the immune system to fight the cancer itself.

“People used to ask me the question, ‘When will there be a cure for cancer?’ And I’ve been doing this for 60 years and I could never answer that question,” Wagner said. “Until recently, until the last three or four or five years.”

  • GenEcon@lemm.ee
    link
    fedilink
    English
    arrow-up
    4
    ·
    11 months ago

    Actually this can lead to a stopping of the clinic phase. If some medicine is too good, its unethical to withheld it from the control group, which can lead to an interruption of the study.